Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thymidylate synthetase - substrate complex formation

P V Danenberg, A Lockshin

    Molecular and Cellular Biochemistry
    |March 5, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dynamic changes in RAS gene status in circulating tumour DNA: a phase II trial of first-line FOLFOXIRI plus bevacizumab for RAS-mutant metastatic colorectal cancer (JACCRO CC-11).

    ESMO open·2022
    Same author

    Studies on the mechanism of fluoropyrimidine cytotoxicity in l1210 cells: correlation with inhibition of thymidylate synthetase but not with incorporation into RNA.

    Pharmaceutical research·2013
    Same author

    Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib).

    The pharmacogenomics journal·2012
    Same author

    TS and ERCC-1 mRNA expressions and clinical outcome in patients with metastatic colon cancer in CONFIRM-1 and -2 clinical trials.

    The pharmacogenomics journal·2011
    Same author

    Quantitative measurement of relative gene expression in human tumors.

    Methods in molecular biology (Clifton, N.J.)·2011
    Same author

    ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine.

    Annals of oncology : official journal of the European Society for Medical Oncology·2006

    Thymidylate synthetase (TSase) interactions with inhibitors like FdUMP are key cancer drug targets. This review explores TSase-dUMP complexes, comparing them to FdUMP and evaluating their therapeutic potential with folate analogs.

    Area of Science:

    • Biochemistry
    • Enzymology
    • Pharmacology

    Background:

    • Thymidylate synthetase (TSase) is a critical enzyme in DNA synthesis.
    • The ternary complex of TSase-FdUMP-5,10-CH2H4PteGlu is a significant target in cancer therapy.
    • FdUMP is the active metabolite of the anti-cancer drug 5-fluorouracil.

    Purpose of the Study:

    • To investigate the experimental basis for comparing TSase-dUMP complexes to TSase-FdUMP complexes.
    • To evaluate the chemotherapeutic potential of TSase-dUMP complexes in the presence of folate analogs.

    Main Methods:

    • Literature review of existing studies on TSase complexes.
    • Analysis of enzyme kinetics and structural data for TSase-dUMP and TSase-FdUMP interactions.

    Main Results:

    Related Experiment Videos

    • The study examines the properties of TSase-dUMP complexes.
    • It assesses the analogy between dUMP and FdUMP interactions with TSase.
    • Data on the therapeutic value of TSase-dUMP complexes with folate analogs is evaluated.

    Conclusions:

    • The review provides insights into the mechanistic similarities and differences between dUMP and FdUMP binding to TSase.
    • It highlights the potential of TSase-dUMP complexes as a basis for novel chemotherapeutic strategies.